small molecule

ZURZUVAE

ZURANOLONE

Loss of exclusivityAugust 2037latest FDA-listed patent expiry

CompanyBiogen →See this company's full patent-cliff portfolio

Drug detail

Brand name	ZURZUVAE
Active ingredient	ZURANOLONE
Strength	25MG
Dosage form	CAPSULE
Route	ORAL
Modality	Small molecule
FDA approval	October 2023
Marketing status	RX

Listed patents

Patent	Expires	Type
11884696	August 2037	use U-2552
11236121	August 2037	substance
10342810	April 2034	use U-2552
10172871	April 2034	use U-2552
9512165	April 2034	substance, product

Regulatory exclusivity

Code	Expires
NCE	October 2028

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

Drug detail

Listed patents

Regulatory exclusivity

More from Biogen